Hyloris Announces Start of Phase 2 Study of Miconazole-Domiphen Bromide Vaginal Cream in Vulvovaginal Candidiasis
Miconazole-Domiphen Bromide (MCZ-DB) vaginal cream is a candidate product for the treatment of recurring vulvovaginal candidiasis (rVVC), which affects 10% of all women globallyTopline results anticipated in H2 2022 Liège, ...